适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
肥胖 | 临床1期 | 法国 | 2022-04-07 |
N/A | - | EVE-EXE as second/third line and previous CDK 4/6i-containing treatment as first-line | (鹽鹹鬱網積膚獵構願遞) = 鹽糧網膚築夢鏇簾遞蓋 襯廠襯築顧鏇範築築遞 (構醖糧觸糧壓餘範鬱淵 ) | 不佳 | 2020-09-17 | ||
EVE-EXE as second/third line and no previous CDK 4/6i | (鹽鹹鬱網積膚獵構願遞) = 鹽衊繭觸獵夢餘鏇齋製 襯廠襯築顧鏇範築築遞 (構醖糧觸糧壓餘範鬱淵 ) |